Privia Health Group’s (PRVA) Buy Rating Reiterated at Needham & Company LLC
Needham & Company LLC reissued their buy rating on shares of Privia Health Group (NASDAQ:PRVA – Free Report) in a research note released on Friday morning,Benzinga reports. The firm currently has a $30.00 target price on the stock. Several other research analysts have also recently weighed in on the stock. Stephens reiterated an “overweight” rating […]
Needham & Company LLC reissued their buy rating on shares of Privia Health Group (NASDAQ:PRVA – Free Report) in a research note released on Friday morning,Benzinga reports. The firm currently has a $30.00 target price on the stock. Several other research analysts have also recently weighed in on the stock. Stephens reiterated an “overweight” rating […]
